Display Settings:

Format

Send to:

Choose Destination
    Science. 1998 Aug 7;281(5378):838-42.

    DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.

    Source

    Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10021, USA.

    Abstract

    Dopaminergic neurons exert a major modulatory effect on the forebrain. Dopamine and adenosine 3',5'-monophosphate-regulated phosphoprotein (32 kilodaltons) (DARPP-32), which is enriched in all neurons that receive a dopaminergic input, is converted in response to dopamine into a potent protein phosphatase inhibitor. Mice generated to contain a targeted disruption of the DARPP-32 gene showed profound deficits in their molecular, electrophysiological, and behavioral responses to dopamine, drugs of abuse, and antipsychotic medication. The results show that DARPP-32 plays a central role in regulating the efficacy of dopaminergic neurotransmission.

    PMID:
    9694658
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk